MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Protective approach targeting NF-kB/ Nrf2 signaling and neuroinflammation using Apigenin in LPS induced Parkinsonism in experimental rats

    S. Singh (Moga, India)

    Objective: 1. Apigenin as a protective strategy to prevent neuroinflammation in PD.2. To find behavioral, neurochemical and histopathological changes in LPS induced PD. Background: Parkinson’s…
  • 2022 International Congress

    A rare case of Hyperkinetic Movement disorder

    P. A, T. K, S. S, C. P, P. Peter (SALEM, India)

    Objective: We present a case of hyperkinetic movement disorder in a 47 year old male with 3 year history of behavioural changes, chorea and dystonia…
  • 2022 International Congress

    Melatonin attenuates the bidirectional Gut-Brain axis mediated inflammation caused by Ambient Particulate Matter (PM2.5) and averts neurodegeneration

    SAM. Panda, VGM. Naidu (Guwahati, India)

    Objective: To explore the therapeutic potential of melatonin in attenuating the PM2.5 induced inflammation and neurodegeneration through the Gut-brain axis in C57BL/6 mice. Background: The…
  • 2022 International Congress

    Three patients with PSP presenting with a logopenic pattern of aphasia: expanding the phenotype of language impairment in PSP.

    S. Lyons, R. Walsh, T. Lynch, S. O'Dowd (Dublin, Ireland)

    Objective: To investigate the a series of cases presenting with apparent logopenic variant primary progressive aphasia who then developed symptoms suggestive of PSP. Background: Deficits…
  • 2022 International Congress

    A Pilot Feasibility Study of Medium Chain Triglyceride Nutritional Ketosis and Parkinson’s Disease

    A. Choi, M. Delgado, K. Chen, S. Chung, A. Courville, S. Turner, S. Yang, K. Airaghi, I. Dustin, P. Mcgurrin, M. Hallett, D. Ehrlich (Sun City, USA)

    Objective: To determine if nutritional ketosis supplemented by medium chain triglycerides (MCT) over the course of 2-3 weeks is acceptable and feasible in patients with…
  • 2022 International Congress

    Implementing Team-Based Outpatient Palliative Care in Parkinson’s Foundation Centers of Excellence (COE): Study Design

    M. Dini, S. Seshadri, S. Norton, J. Holtrop, P. Auinger, N. Yarab, B. Kluger (New York, USA)

    Objective: To describe the study design and early lessons of an implementation project aiming to make integrated palliative care (PC) a new standard of care…
  • 2022 International Congress

    Abnormal streamline density of the tremor network in tremor dominant Parkinson’s disease and Essential tremor plus syndrome

    S. Prasad, J. Saini, R. Bharath, P. Pal (Bangalore, India)

    Objective: To evaluate streamline density (SD) of the basal ganglia-thalamocortical (BGTC) and cerebello-thalamocortical (CTC) network in tremor dominant Parkinson’s disease (TDPD) and essential tremor plus…
  • 2022 International Congress

    DBS Targeting in a Neuromodulation Monitoring Unit – First 30 cases

    T. Sanger, J. Maclean, A. Tongol, J. Olaya, M. Liker (Orange, USA)

    Objective: We evaluate potential targets for Deep Brain Stimulation (DBS) based on test stimulation and chronic recording from temporary depth electrodes placed in a Neuromodulation Monitoring…
  • 2022 International Congress

    A progress update on the Critical Path for Parkinson’s consortium’s pre-competitive 3DT initiative

    M. Müller, J. Cosman, J. Adams, R. Badawy, R. Bhatnagar, B. Bloem, C. Carroll, N. Cooray, T. Dam, D. Dexter, M. Dockendorf, R. Dorsey, M. Frasier, L. Garcia-Gancedo, D. Hill, M. Kostrzebski, E. Kunka, M. Lindemann, J. Mammen, M. Meinders, A. Mirelman, G. Roussos, S. Sardar, T. Simuni, R. Speck, G. Stebbins, K. Ward Barowicz, J. Cedarbaum, D. Stephenson (Tucson, USA)

    Objective: To provide a progress update on the Critical Path for Parkinson’s (CPP) consortium’s “Digital Drug Development” (3DT) initiative, which was established in 2019 with…
  • 2022 International Congress

    Prospective, Multicenter, International Registry of Deep Brain Stimulation for Essential Tremor

    G. Deuschl, R. Schuurman, G. Loret, N. Kovacs, M. Blázquez Estrada, F. Clement, J. Il Lee, L. Chen, R. Jain (Kiel, Germany)

    Objective: This is a new Essential Tremor (ET) patient registry for patients implanted with a multiple-source, constant-current DBS system capable of providing directionality for use…
  • « Previous Page
  • 1
  • …
  • 123
  • 124
  • 125
  • 126
  • 127
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley